Educational videos for people newly diagnosed with sarcoma
Official title: Evaluating the Use of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction.
Run by Mount Sinai Hospital, Canada · NCT06805773 · Data updated 2026-11-12
This project will test whether watching four short sarcoma-specific videos before the first oncology visit helps newly diagnosed adults (or their caregivers) better understand the disease and treatment options.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Mount Sinai Hospital, Canada Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | May 5, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT06805773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with histologically confirmed advanced/metastatic sarcoma who have not received prior systemic treatment, or their caregivers, who can read and write English and provide informed consent.
✕Probably not a fit
People who have already been seen by a medical oncologist for their sarcoma, those with previous systemic sarcoma treatment, those unable to consent, or those who cannot read English are not likely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with newly diagnosed advanced or metastatic sarcoma (or their caregivers) will watch four targeted educational videos before their first appointment with a medical oncologist. Participants will complete questionnaires measuring their knowledge and understanding before the videos and again after the first clinic visit. The intervention is compared with standard of care education provided in the clinic. The setting is Mount Sinai Hospital in Toronto and enrollment requires informed consent and English literacy.
Why it matters
Potential benefit: If successful, patients may come into their first oncology visit better informed and more prepared to discuss treatment choices, improving communication and decision-making.
How similar studies have gone: Educational video interventions in other cancer settings have often improved patient knowledge and preparedness, though using this approach specifically for sarcoma is relatively uncommon.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Signed written and voluntary informed consent. 2. Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma. 3. Age ≥ 18 years. 4. Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma. 5. Willing/able to complete questionnaires. 6. Able to read and write in English. Exclusion Criteria: 1. Inability to provide informed consent. 2. Previously seen by a medical oncologist for their sarcoma.
Where it's running
-
Mount Sinai Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Clinical Trials Manager
- Email: Oncology.Research@sinaihealth.ca
- Phone: 416-586-8440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MIGHTY: CAR T cells targeting B7-H3 for pediatric, teen, and young adult sarcoma
This Phase 1 trial tests autologous hBRCA84D CAR T cells in kids, teens, and young adults (1–24) with relapsed or refractory RMS, ES, or DSRCT to see if the therapy is feasible and safe.
-
Lifileucel (Tumor-infiltrating lymphocytes) for advanced soft tissue sarcoma
This study tests lifileucel, a cell therapy made from a patient’s own tumor cells, in adults with unresectable or metastatic soft tissue sarcoma who have had prior treatments to see if it helps shrink tumors and improve outcomes.
-
Domatinostat with Sirolimus for relapsed or refractory sarcoma and osteosarcoma
This study tests whether the cancer drugs domatinostat and sirolimus together can help adolescents and adults whose sarcoma or osteosarcoma has come back or stopped responding to standard therapy.
-
Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers
This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.
-
AYA Sarcoma Survivors: Personalized Exercise Program Pilot
This pilot tests a personalized 12-week exercise program for adolescents and young adults with sarcoma to see if a triage tool can connect them with the right rehabilitation and exercise services.
-
Fluorescence-guided surgery to reduce unexpected positive margins in high-grade sarcoma
This phase II trial tests whether adding fluorescence-guided surgery with indocyanine green can lower unexpected positive margins in patients with high-grade sarcoma compared to standard surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.